Cadrenal aligns pipeline into Cardiac Acute Critical Care Franchise, shifts to partnership-driven modelPUBT·Jul 21 at 07:06 AMCVKD+6.09%
Cadrenal's James J. Ferguson III to Resign as Chief Medical Officer, Separation Effective July 31, 2026TradingView·Jul 17 at 03:23 PMCVKD+6.09%
Cadrenal Therapeutics Reports Clinical Data From Phase 2 Study Of CAD-1005rttnews·Jul 13 at 08:52 AMCVKD+6.09%
Cadrenal says Phase 2 trial of CAD-1005 cuts thrombotic events by more than 25% in HITPUBT·Jul 13 at 08:24 AMCVKD+6.09%
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga_article·Jul 6 at 07:05 AMUPC+6.91%LUCY+9.40%
Insider Selling: Cadrenal Therapeutics (NASDAQ:CVKD) CEO Sells 7,400 Shares of StockMarket Beat·Jul 3 at 05:53 AMCVKD+6.09%
Pre-market hot trades in US stocks: ZeroStack up 11.90% in pre-market; Cadrenal Therapeutics down 8.52% in pre-marketPrice Alert·Jul 2 at 06:02 AMZSTK+3.36%CVKD+6.09%
Cadrenal Therapeutics CEO, Chairman Quang X. Pham disposes of 7,400 common shares worth $22,422PUBT·Jul 1 at 08:52 PMCVKD+6.09%
Cadrenal Therapeutics Raises $3.0 Million in Private Placement of Pre-Funded and Common WarrantsTradingView·Jul 1 at 04:33 PMCVKD+6.09%
Cadrenal Therapeutics issues 1.92 million warrants in $3 million private placement priced at $3.125 per sharePUBT·Jul 1 at 04:24 PMCVKD+6.09%
